Semler, E. M., Michell, D. L., Kingsley, P. J., Ramirez, M. A., Massick, C., Castleberry, M., Doran, A. C., Carr, J. J., Marnett, L., Sheng, Q., Linton, M. F., & Vickers, K. C. (2026).泭.泭Atherosclerosis,泭412, 120584.泭
Chemical modifications on RNA, called��epitranscriptomic modifications, help control how RNA works in our cells. Small RNA fragments, known as��tRNA-derived fragments (tDRs), can carry these modifications from their parent RNA. Some of these modified RNAs travel through the blood inside��high-density lipoproteins (HDL), the same particles that carry ���good cholesterol.��� These HDL-associated RNAs (HDL-sRNAs) can influence��immune responses��and may play a role in��atherosclerotic cardiovascular disease (ASCVD).
In this study, we compared HDL-sRNAs from healthy people and patients with advanced ASCVD. Using methods like��LC-MS/MS,泭ARM-seq, and��qPCR, we found that HDL from ASCVD patients had more RNA modifications. We identified a specific fragment,泭tDR-ArgACG, carrying a modification called��1-methyladenosine (m1A), which was more common in ASCVD. When these modified RNAs entered��macrophages, immune cells that drive inflammation in arteries, they changed gene activity, including increasing��TMEM123, a protein that helps immune cells move and stick to tissues. Experiments showed that HDL carrying m1A-tDR-ArgACG boosted TMEM123 in macrophages, and blocking the m1A modification reduced this effect.
These findings suggest that HDL can deliver modified RNAs to immune cells, triggering��inflammation��in atherosclerotic plaques. This reveals a new way that HDL-sRNAs may contribute to cardiovascular disease and points to potential targets for therapy.

Fig. 1��CAC��HDL induces non-classical activation and select immune response pathway and gene expression changes in macrophages��(A) Volcano plot depicting log10 p-adjusted (Q)-value versus log2 fold changes for all differentially expressed (���2.0 absolute fold change) genes in BMDM’s treated with CAC��+��HDL or Ctr-HDL (n��=��3). (B) EGR1-containing gene set pathway analyses (Meta Core) enrichment, ranked by -log10(p-value) with false discovery rate (FDR) shown. (C) mRNA expression by qPCR displaying fold change from BMDMs treated with Ctr-HDL (n��=��9) and CAC+HDL (n��=��14). Statistical analysis assessed by Mann-Whitney��U��test. Data are presented as mean��+s.e.m., ���梯泭&梭喧;泭0.05.